Skip to content
healthcare.dev

DG health omperazole

NDC 55910-713, omeprazole, tablet, orally disintegrating, delayed release, from Dolgencorp Inc.

Product NDC
55910-713
Status
Listed
Labeler
Dolgencorp Inc
Dosage form
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA209400
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55910-713 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OMEPRAZOLE20 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
55910-713-30559100713302 CARTON in 1 CARTON (55910-713-30) / 14 BLISTER PACK in 1 CARTON / 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK
55910-713-55559100713553 CARTON in 1 CARTON (55910-713-55) / 14 BLISTER PACK in 1 CARTON / 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK
55910-713-745591007137414 BLISTER PACK in 1 CARTON (55910-713-74) / 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 55910-713 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55910-713 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55910-713. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.